PGRMC1 Exerts Its Function of Anti-Influenza Virus in the Central Nervous System

• Published in: Microbiology spectrum 2021-10, Vol.9 (2), p.e0073421
• Main Authors: Huang, Kun, Zhang, Yufei, Gong, Wenxiao, Yang, Yong, Jiang, Lili, Zhao, Lianzhong, Yang, Ying, Wei, Yanming, Li, Chengfei, He, Xinglin, Sun, Xiaomei, Zou, Zhong, Jin, Meilin
• Format: Article
• Language: English
• Subjects: Animals; Antiviral Agents - pharmacology; Central Nervous System - metabolism; CNS; Female; H5N6 virus; Host-Pathogen Interactions; Humans; Influenza A virus; Influenza, Human; Lung - virology; Membrane Proteins - genetics; Membrane Proteins - metabolism; Mice; Mice, Inbred BALB C; Mice, Knockout; Orthomyxoviridae Infections; PGRMC1; Receptors, Progesterone - genetics; Receptors, Progesterone - metabolism; Research Article; RIG-I; Transcriptome; Virology; Virus Replication
• ISSN: 2165-0497; 2165-0497
• DOI: 10.1128/Spectrum.00734-21

The influenza A virus (IAV) infection is usually restricted to the respiratory tract and only rarely enters the central nervous system (CNS) and causes neurological symptoms. However, the roles of host factors involved in IAV infection in the CNS remain largely undetermined. Therefore, we aimed to characterize the host responses to IAV infection in the brain. We isolated a strain of IAV H5N6, which is neurotoxic and highly pathogenic to mice. High-throughput RNA sequencing (RNA-seq) revealed 240 differentially expressed genes in IAV-infected brains. Among the significantly downregulated genes, we focused on the gene encoding progesterone receptor membrane component-1 ( ) and observed that IAV H5N6 infection clearly inhibited in both neuroblastoma and glioma cells. Furthermore, treatment with AG205, a -specific inhibitor, or knockout promoted H5N6 multiplication , while overexpression of resulted in opposite effects. Furthermore, AG205 treatment or knockout significantly inhibited the retinoic acid-inducible gene I (RIG-I)-mediated interferon beta (IFN-β) signaling pathway and reduced the levels of several antiviral proteins (Mx1 and ISG15). In addition, -mediated regulation of IFN signaling relied on inhibition of the expression and ubiquitination of RIG-I. The loss of leads to an increased susceptibility of mice (brain and lung) to influenza A virus infection. Conclusively, our results show for the first time that IAV H5N6 downregulates expression to contribute to virus proliferation by inhibiting RIG-I-mediated IFN-β production in the brain. These findings may offer new insights regarding the interplay between IAV and host factors that may impact IAV pathogenicity in the brain. Central nervous system (CNS) disease is one of the most common extra-respiratory tract complications of influenza A virus (IAV) infections. However, there is still little knowledge about IAV regulating host responses in brain. In this study, we identified progesterone receptor membrane component-1 (PGRMC1) as a novel host factor involved in the replication and propagation of IAV H5N6 in the host brain. We also observed that PGRMC1 antagonism was required for viral evasion from the host immune response during IAV infection via inhibition of the retinoic acid-inducible gene I (RIG-I)-mediated interferon beta (IFN-β) signaling pathway and downstream antiviral gene expression. This study revealed a newly identified regulatory mechanism used by IAV H5N6 to ensure its life cycle in the